Our scientific advisors

Our Grant Review Board ensure that we only fund the best research that will take us closer to effective diagnostics, preventions and treatments for dementia.

Grant Review Board

Our Grant Review Board ensure that we only fund the best research that will take us closer to effective diagnostics, preventions and treatments for dementia.

Dr Alexander Gerhard

Dr Gerhard is a clinician based at the University of Manchester. He wants to understand the correlation between clinical symptoms and other aspects of neurodegenerative disease, particularly inflammation.

Prof Bettina Platt

Prof Platt is based at the University of Aberdeen. Her research focuses on trying to understand the biological pathways triggered when nerve cells are damaged in Alzheimer’s.

Dr Robert Williams

Dr Williams is based at the University of Bath and is interested in the break-down in communication between nerve cells and how this can be stopped.

Prof David Brooks

David Brooks is a Professor of PET Clinical Science based at Newcastle upon Tyne University and visiting Professor of Neurology at Imperial College London. He wants to develop better brain imaging tools to help diagnose dementia.

Prof Delphine Boche

Prof Boche is based at the University of Southampton and researches how inflammation in the brain is altered in dementia.

Prof Lesley Jones

Prof Jones is based at the University of Cardiff. Her work involves understanding the biological pathways altered by different genetic risk factors for Alzheimer’s. Prof Jones leads the Alzheimer’s Research UK Cardiff Research Network.

Prof Stephen Wharton

Prof Wharton is based at the University of Sheffield. He is interested in the physical changes that occur in the brain associated with ageing and dementia.

Dr Wendy Noble

Dr Noble is based at King’s College London. She researches nerve cell damage and how the brain’s support cells can affect this.

Prof Tara Spires-Jones

Dr Spires-Jones is based at the University of Edinburgh. She studies how toxic proteins in Alzheimer’s disrupt nerve cell communication.

Prof Johannes Attems

Prof Attems is based at the University of Newcastle. He uses donated brain tissue to understand more about the biological changes that occur in Alzheimer’s. You can learn more about brain donation on the blog.

Dr John-Paul Taylor

Dr Taylor is a clinician based at Newcastle University. He is interested in mechanisms causing cognitive changes in neurodegenerative diseases as well as developing new biomarkers.

Dr Katie Lunnon

Dr Lunnon is based at the University of Exeter. Her work focuses on the genetics underpinning dementia. She uses computational techniques to better understand complex genetic interactions. Dr Lunnon co-chairs the Alzheimer’s Research UK South West Research Network.

Dr Jill Richardson

Dr Richardson is a Director at the pharmaceutical company GlaxoSmithKline. She oversees the development of drugs for Alzheimer’s.

Dr David Llewellyn

Dr Llewellyn is based at the University of Exeter. He is interested in how lifestyle factors increase dementia risk.

Prof Simon Mead

Prof Mead is a clinician based at University College London. His work focuses on the genetics underpinning different forms of dementia.

Dr Michael Coleman

Prof Coleman is based at the University of Cambridge. He researches nerve cell damage and how the transport of biological molecules changes with age.

Professor Patricia Salinas

Professor Salinas is based at University College London. She researches how nerve cells communicate and how this can be disrupted in disease.

Dr Mike O’Neill

Dr O’Neill is Head of the Neurodegeneration Group at the pharmaceutical company Lily. He leads a group of researchers investigating new treatments for Alzheimer’s.

Dr Jody Mason

Dr Mason is based at the University of Bath. He is interested in understanding how proteins work and how they can go wrong in disease.